Clinical Trial Update: Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the efficacy and safety of VX-993 for pain associated with diabetic peripheral neuropathy and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy

Drugs mentioned

• VX-993

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Diabetic Peripheral Neuropathic Pain | Phase 2 | Status: RECRUITING